APPLICATION
ANDA210241
TYPE
ANDA
ORIGINAL APPROVAL
2018-11-21
LATEST ACTION
2020-06-19
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Prescription
Products
POTASSIUM CHLORIDEPrescription
POTASSIUM CHLORIDE 20MEQ · FOR SOLUTION · ORAL
Approval history
2020-06-19Labeling · Supplement 3 · standardAP
2020-06-19Labeling · Supplement 2 · standardAP
2018-11-21UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.